GBT Technologies Inc.

What they do

GBT Technologies was incorporated in Nevada on July 22, 2009 and was formerly known as Gopher Protocol Inc. It targets IoT and AI-enabled networking and tracking markets, including wireless mesh network platforms, an intelligent human body vitals device, and asset-tracking IoT. Revenue historically came from IT consulting services, technology licensing, and e-commerce electronics sales, the last of which was terminated on July 1, 2023. Its main physical activity now runs through subsidiary GBT Tokenize Corp., which holds the technology portfolio.

Revenue drivers

• IT consulting services — One of two identified legacy revenue sources; the 10-Q says the company 'derived revenues from' IT consulting services, but no segment-level revenue figures are disclosed in the excerpts.
• Technology licensing — The company licenses its technology portfolio, including the Avant-AI technology developed by GBT Tokenize, which produced its first commercial transaction on April 3, 2023.
• E-commerce electronics sales — Previously a revenue source through e-commerce platforms, but this operation was terminated on July 1, 2023 and is not a current driver.
• Patent monetization — Effective March 20, 2024, GBT Tokenize signed a Patent Purchase Agreement with VisionWave Technologies Inc. covering patents for machine-learning radio-wave imaging; terms and amounts are not disclosed in the excerpts.

Recent performance

For the three months ended June 30, 2026, operating expenses were $77,628 versus $114,010 a year earlier, a decrease of $36,382 or 32%, which management attributed primarily to the absence of marketing expenses. Other expenses were $308,313 compared with $101,544, and the net loss widened to $385,941 from $215,554. The latest balance sheet shows total assets of $83,652, total liabilities of $11.4 million and shareholder equity of negative $10.2 million as of June 30, 2026. Cash and equivalents were $262 as of March 31, 2026. Annual revenue was $0.00 in 2023, after $90,000 in 2022 and $180,000 in 2021.

Strategy

The stated focus is on growing markets for IoT and AI-enabled networking and tracking, including wireless mesh networks and an intelligent human body vitals device. The company says GBT Tokenize has developed a vital device ready for commercialization and has begun developing or licensing code sources. It entered the 2023 Tokenize Agreement with Magic Internacional Argentina FC, S.L. and GBT Tokenize on July 20, 2023 through subsidiary Greenwich International Holdings. It also moved to monetize part of the portfolio by selling VisionWave certain radio-wave imaging patents.

Risks

• No revenue and negative working capital — Annual revenue was $0.00 in 2023; total liabilities of $11.4 million exceed total assets of $83,652 as of June 30, 2026.
• Minimal liquidity — Cash and equivalents stood at just $262 as of March 31, 2026.
• History of operating losses — The company reported a net loss of $385,941 for the three months ended June 30, 2026, and the 10-K risk factors state results of operations have not resulted in profitability.
• Need for additional capital — The 10-K risk factors state the company will require additional capital to support business growth and that this capital might not be available on acceptable terms, if at all.

Outlook

The excerpts provided do not include a quantified revenue or earnings forecast. Management's stated direction is continued development and commercialization of the GBT Tokenize vital device and other portfolio technologies, alongside licensing and joint-venture efforts. The 10-K risk factors caution that the company needs additional capital and has not generated positive operating cash flow. Material 8-K events since the prior 10-K include multiple director or officer changes, a change of accountants, and a material agreement.